Edwards Lifesciences Corporation

NYSE:EW Stock Report

Market Cap: US$44.7b

Edwards Lifesciences Past Earnings Performance

Past criteria checks 2/6

Edwards Lifesciences has been growing earnings at an average annual rate of 6.8%, while the Medical Equipment industry saw earnings growing at 15.4% annually. Revenues have been growing at an average rate of 3.9% per year. Edwards Lifesciences's return on equity is 13.3%, and it has net margins of 24.8%.

Key information

6.85%

Earnings growth rate

7.92%

EPS growth rate

Medical Equipment Industry Growth8.90%
Revenue growth rate3.90%
Return on equity13.26%
Net Margin24.85%
Next Earnings Update30 Oct 2025

Recent past performance updates

Recent updates

Edwards Lifesciences: Inflection Incoming, But When?

Oct 14

Why Edwards Lifesciences Corporation (NYSE:EW) Could Be Worth Watching

Sep 20
Why Edwards Lifesciences Corporation (NYSE:EW) Could Be Worth Watching

Here's What's Concerning About Edwards Lifesciences' (NYSE:EW) Returns On Capital

Sep 05
Here's What's Concerning About Edwards Lifesciences' (NYSE:EW) Returns On Capital

Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Jul 16
Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up

Apr 15
Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up

Edwards Lifesciences (NYSE:EW) Will Want To Turn Around Its Return Trends

Apr 01
Edwards Lifesciences (NYSE:EW) Will Want To Turn Around Its Return Trends

Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead

Mar 23

A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Mar 18
A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

At US$71.45, Is It Time To Put Edwards Lifesciences Corporation (NYSE:EW) On Your Watch List?

Feb 26
At US$71.45, Is It Time To Put Edwards Lifesciences Corporation (NYSE:EW) On Your Watch List?

Edward Lifesciences: A Closer Look At Growth And Valuation

Jan 05

Edwards Lifesciences Corporation's (NYSE:EW) Price Is Out Of Tune With Earnings

Dec 23
Edwards Lifesciences Corporation's (NYSE:EW) Price Is Out Of Tune With Earnings

Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Dec 09
Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

At US$71.27, Is Edwards Lifesciences Corporation (NYSE:EW) Worth Looking At Closely?

Nov 26
At US$71.27, Is Edwards Lifesciences Corporation (NYSE:EW) Worth Looking At Closely?

Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Nov 11
Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences Q3: Divesting Critical Care And Focusing On Structural Hearts

Oct 25

Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut

Jul 26

Edwards Lifesciences Corp Looks Bullish (Technical Analysis)

Jun 22

Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)

May 09

Revenue & Expenses Breakdown

How Edwards Lifesciences makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:EW Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 255,6851,4131,8801,055
31 Mar 255,5221,4401,8261,051
31 Dec 245,4401,4011,7891,053
30 Sep 245,3201,3881,7131,024
30 Jun 245,2091,3611,6731,013
31 Mar 245,1021,2471,628985
31 Dec 235,0101,2231,581963
30 Sep 235,0921,2881,576953
30 Jun 235,1681,2961,571944
31 Mar 235,2791,4511,578951
31 Dec 224,4641,3241,357844
30 Sep 225,3641,4591,581946
30 Jun 225,3551,4551,568950
31 Mar 225,3571,5391,534925
31 Dec 215,2331,5031,494903
30 Sep 215,0951,4771,409866
30 Jun 214,9251,4621,351824
31 Mar 214,4748511,252780
31 Dec 204,3868231,229761
30 Sep 204,3697941,235759
30 Jun 204,3227441,234759
31 Mar 204,4841,1081,268769
31 Dec 194,3481,0471,242753
30 Sep 194,1527741,182722
30 Jun 193,9647251,146688
31 Mar 193,8217651,113650
31 Dec 183,7237221,088622
30 Sep 183,6347121,080606
30 Jun 183,5496571,055587
31 Mar 183,4475601,023567
31 Dec 173,435584984553
30 Sep 173,315745948521
30 Jun 173,232716933491
31 Mar 173,150657918469
31 Dec 162,964570905442
30 Sep 162,867552892426
30 Jun 162,743528875414
31 Mar 162,601515860399
31 Dec 152,494495851383
30 Sep 152,441463852369
30 Jun 152,433440862356
31 Mar 152,391874863347
31 Dec 142,323811858347

Quality Earnings: EW has high quality earnings.

Growing Profit Margin: EW's current net profit margins (24.8%) are lower than last year (26.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: EW's earnings have grown by 6.8% per year over the past 5 years.

Accelerating Growth: EW's earnings growth over the past year (3.8%) is below its 5-year average (6.8% per year).

Earnings vs Industry: EW earnings growth over the past year (3.8%) did not outperform the Medical Equipment industry 12.6%.

Return on Equity

High ROE: EW's Return on Equity (13.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/27 03:56
End of Day Share Price 2025/10/24 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Edwards Lifesciences Corporation is covered by 55 analysts. 32 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David RescottBaird
Matthew MiksicBarclays
Adam FeinsteinBarclays